Speaker(s): 

James Kamau, DO, Hematology/Oncology PGY5 Fellow, Geisinger - has nothing to disclose.

Maria Saimbert, PharmD, Oncology PGY2 Pharmacy Resident, Geisinger - has nothing to disclose. 

Moderator(s): 

Tristan Maiers, PharmD, BCOP, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Compare and contrast, similarities and uniqueness of BiTE and CAR-T therapies
• Defend for or against use of the debated therapies.
• Apply pros and cons of the debated therapies in the context of Diffuse large B-cell Lymphoma

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Tristan Maiers, PharmD, BCOP, Rajiv Panikkar, MD, Michele Long, BSN, Jaime Weeder, NP and Christopher Kashi, PA-C have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commerical Support for this Session

None.